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________________ 
 
OPINION 
________________ 
 
AMBRO, Circuit Judge 
 
 Appellants—three companies and three individuals—jointly appeal their 
convictions for criminal contempt and Appellants Omar and Ahmad Desoky appeal their 
sentences.  We affirm the convictions but vacate and remand Omar and Ahmad Desoky’s 
sentences for further findings.  
I. Background 
 In 2010, following a civil suit, Mohamed Desoky and the three dietary supplement 
companies he ran—Quality Formulations Laboratories (QFL), American Sports Nutrition 
(ASN), and Sports Nutrition International (SNI)—entered into a court-approved Consent 
Decree with the federal Food and Drug Administration (FDA) halting production at the 
companies’ Paterson, New Jersey manufacturing facility.  The Consent Decree provided 
that  
[QFL, ASN, SNI and Mohamed Desoky] and each and all of their officers, agents, 
employees, successors, and assigns, and any persons in active concert or 
participation with any of them who receive notice of this Decree, are permanently 
restrained and enjoined . . . from directly or indirectly receiving, manufacturing, 
preparing, packing, labeling, and distributing at their plant located [in] . . . 
Paterson, New Jersey . . . or any new location(s) at which the Defendants receive, 
manufacture, prepare, pack, label, hold, or distribute articles of food, any article of 
food unless and until [described] conditions have been met[.]  
 
App. at 78, Consent Decree, para. VII.  It also required that  
[QFL, ASN, SNI and Mohamed Desoky] shall notify FDA in writing at least thirty 
(30) calendar days before any change [in] ownership, name, or character of their 
business, including reorganization, relocation, dissolution, assignment, or lease or 
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sale of the business or any asset of the business, such as buildings, equipment, or 
inventory, that may affect compliance with the obligations arising from this 
Decree. 
 
 Id. at 92, Consent Decree, para. XV.  
 Pursuant to the Consent Decree, the Paterson facility was shut down.  
Subsequently, manufacture of Appellants’ products began at a facility in Congers, New 
York owned by ADH Health Products (―ADH‖).  On discovering this manufacturing, the 
FDA filed an order to show cause alleging criminal contempt by Mohamed, the three 
companies, and Mohamed’s two sons and company employees, Ahmad and Omar.  The 
Government alleged that Appellants willfully violated the Consent Decree by 
manufacturing products at the Congers facility.  Appellants asserted a good faith defense, 
arguing that they contracted with ADH to manufacture QFL products, and they believed 
this third-party manufacturing was permitted by the Consent Decree.   
 Evidence presented at trial showed that the Congers facility manufactured QFL 
products, that Appellants sent raw material and equipment from Paterson to Congers, that 
former and current QFL employees worked on the products in Congers, and that QFL 
paid those employees in cash.   Appellants did not disclose the activities at Congers to the 
FDA, including during two FDA inspections of the Paterson facility.  
 In addition to the activities at Congers, some raw ingredients were shipped to the 
Paterson facility, Ahmad brought some products manufactured at ADH to the Paterson 
facility to be shipped to customers, and Ahmad loaded two pallets of product from the 
Paterson facility to a truck owned by Performance Food Centers.  The Government 
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alleged that these actions also violated the Consent Decree, and Appellants asserted a 
good faith defense to these charges as well.  
 Appellants were convicted of criminal contempt.  Mohamed was sentenced to 40 
months’ imprisonment.  Ahmad and Omar were each sentenced to 34 months’ 
imprisonment, and  the companies were fined.  All appeal.
1
 
II. Discussion 
 Appellants raise four challenges to their convictions and one to a sentencing 
enhancement applied to Omar and Ahmad Desoky.         
  A. Exclusion of Mary Richardson’s Testimony 
 The District Court excluded Appellants’ offered testimony of Mary Richardson, an 
expert consultant they hired to help them comply with the FDA’s requirements in order to 
avoid and then lift the production shut-down.  Richardson would not have testified about 
the charged conduct.  Instead, her testimony related solely to Appellants’ efforts to 
remediate the issues identified at the Paterson facility.   
 We review a district court’s decision to admit evidence for abuse of discretion.  
United States v. Givan, 320 F.3d 452, 460 (3d Cir. 2003).  Some evidence of earlier 
―good acts‖ evidence may be admissible to show a defendant lacked wrongful intent in 
later behavior.  See United States v. Garvin, 565 F.2d 519, 522 (8th Cir. 1977) (evidence 
of correctly submitted applications for approximately 18 insurance policies admissible to 
show lack of intent to commit a scheme to defraud); United States v. Shavin, 287 F.2d 
                                              
1
 The District Court had jurisdiction pursuant to 18 U.S.C. § 3231, and we have appellate 
jurisdiction under 28 U.S.C. § 1291. 
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647, 654 (7th Cir. 1961) (evidence of properly submitted medical bills admissible to 
show lack of intent to defraud with later medical bills).   
 But Richardson’s testimony is not of this sort.  Evidence that Appellants 
undertook ameliorative efforts at Paterson does not negate the Government’s theory—
apparently adopted by the jury—that Appellants engaged in simultaneous efforts to 
improve the Paterson plant and to continue manufacturing elsewhere, with the latter 
actions violating the Consent Decree. 
 In addition, Richardson’s testimony would have raised ancillary issues about the 
initial problems at Paterson and the Appellants’ ameliorative efforts.  The District Court 
concluded this outweighed any potentially probative value of the testimony.  We agree, 
and, moreover, discern no harm in excluding Richardson’s testimony.  United States v. 
Berrios, 676 F.3d 118, 131 (3d Cir. 2012).  Appellants provided uncontradicted evidence 
at trial about their efforts at Paterson, and their counsel were able to argue to the jury that 
these efforts demonstrated their lack of willfulness to violate the decree.  In this context, 
the District Court did not err in excluding the testimony.    
 B. Jury Instruction on a Good Faith Defense 
 Appellants also challenge two aspects of the jury charge on their good faith 
defense.  They argue that the Court improperly instructed the jury: (1) that an honest 
misunderstanding of the order must be plausible; and (2) that a defendant does not act in 
good faith if he also knowingly made false statements, representations, or purposeful 
omissions.  The first part we review de novo because Appellants objected to the language 
at trial.  United States v. Berrios, 676 F.3d at 136.  Appellants contend that we should 
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review the false statements instructions de novo because they omit key language in their 
requested charge.  While we doubt that merely requesting an instruction contrary to the 
one given sufficiently informs the Court of the specific objection, thus preserving the 
issue for appeal, Fed. R. Crim. P. 30(d); United States v. Russell, 134 F.3d 171, 178–79 
(3d Cir. 1998), we discern no error under either a de novo or plain error review.  
 The language used by the District Court on plausibility comes from our analysis of 
a good faith defense in Taberer v. Armstrong World Industries, Inc., 954 F.2d 888, 909 
(3d Cir. 1992).  Although Appellants allege error in this instruction, we consider jury 
instructions as a whole, and here find that the jury was properly instructed that a 
defendant did not commit criminal contempt if he acted under an honest, although 
incorrect, misunderstanding of the court order.  United States v. Gross, 961 F.2d 1097, 
1103 (3d Cir. 1992) (―[T]he good faith instruction [i]s simply a reiteration that the 
government must carry its burden in demonstrating that the accused acted knowingly and 
willfully . . . .‖).  We also find no error in the Court’s instruction that a defendant does 
not act in good faith if he makes false statements, representations, or purposeful 
omissions.  As such, there is no support for Appellants’ argument that the jury might 
have determined that they were not entitled to a good faith defense because of a false 
statement or omission unrelated to the charged conduct.   
 C. Sufficiency of the Evidence on the Aiding and Abetting Charge 
 Omar and Ahmad challenge the sufficiency of the evidence that they aided and 
abetted the other Appellants’ failure to notify the FDA of the companies’ relocation from 
Paterson to Congers. When reviewing a jury verdict for insufficiency of evidence, we 
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consider the evidence in a light most favorable to the Government, and will affirm unless 
no reasonable jury could find the essential elements of the charged offense beyond a 
reasonable doubt.  United States v. Gatlin, 613 F.3d 374, 380 (3d Cir. 2010).   Aiding and 
abetting has four elements.  ―First, the person who is being aided must be intentionally 
committing a crime; second, the aider or abettor must know that the other is committing a 
crime; third, the aider or abettor must have the purpose to aid that other to commit the 
crime; and, finally, fourth, the aider must in fact render aid or assistance.‖  United States 
v. Nolan, 718 F.2d 589, 592 (3d Cir. 1983).   Sufficient evidence was presented at trial 
for a reasonable jury to conclude that all four elements were met.  Omar and Ahmad 
knew that Mohamed had failed to inform the FDA of the move to Congers, a violation of 
the Consent Decree, and they successfully assisted him and the other Appellants in 
concealing the relocation.  
 D. Closing Arguments 
 Appellants also argue that the prosecutors made a number of improper statements 
during closing argument.  We review a district court’s ruling on contemporaneous 
objections to the statements for abuse of discretion.  United States v. Brennan, 326 F.3d 
176, 182 (3d Cir. 2003).  To determine whether a district court abused its discretion, we 
must consider whether the prosecutor engaged in misconduct, and, if so, whether the 
remarks were harmless.  United States v. Rivas, 493 F.3d 131, 139–40 (3d Cir. 2007).  
We review statements to which Appellants did not object for plain error.  Brennan, 326 
F.3d at 182.  Although we are troubled by the prosecutor’s reference to defense counsels’ 
attack on a witness’s credibility as ―disgusting‖ and ―ridiculous,‖ we do not think this 
9 
 
statement alone, or in combination with the other challenged comments, prejudiced 
Appellants.  The other challenged comments do not amount to misconduct, nor have 
Appellants shown prejudice as a result of these statements, alone or in combination. 
 E. Sentencing Enhancement Applied to Omar and Ahmad 
 Omar and Ahmad also challenge the District Court’s application of a three-level 
enhancement under section 3B1.1(b) of the United States Sentencing Guidelines.  We 
review the factual findings supporting a district court’s application of the Guidelines for 
clear error, and exercise plenary review over a court’s interpretation of the Guidelines.  
United States v. Grier, 475 F.3d 556, 570 (3d Cir. 2007) (en banc).  Section 3B1.1(b) 
provides for an enhancement ―[i]f the defendant was a manger or supervisor‖ and the 
criminal activity was extensive.  U.S.S.G. § 3B1.1(b).  It is applicable in two situations.  
First, the enhancement is proper if the defendant is a ―manager, or supervisor of one or 
more other participants.‖ § 3B1.1(b) cmt. 2.  A participant is defined as someone who is 
―criminally responsible for the commission of the offense‖ even if not convicted.  
§ 3B1.1(b) cmt. 1; United States v. Katora, 981 F.2d 1398, 1404–05 (3d Cir. 1992).  In 
addition, the defendant must have more than legal management responsibility over the 
participant; he must have actually managed or supervised the participant’s illegal 
conduct.  United States v. DeGovanni, 104 F.3d 43, 44 (3d Cir. 1997) (―[O]ne is only a 
supervisor under U.S.S.G. § 3B1.1(c) when he is so involved in, and connected to, the 
illegal activity of others that he actually supervises their illegal conduct . . . .‖).  
Alternately, the role enhancement applies if the defendant ―exercised management 
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responsibility over the property, assets, or activities of a criminal organization.‖ § 3B1.1 
cmt. 2.    
 Here the District Court determined that the criminal activity was extensive, but did 
not make any factual findings regarding whether Omar or Ahmad managed or supervised 
the unlawful activities of a criminally culpable participant or that a criminal organization 
existed over which Omar and Ahmad exercised management responsibility.  Moreover, 
the Court did not determine whether the two unindicted employees the Government 
asserts were managed or supervised were criminally culpable.  To sort matters out, we 
remand so the District Court can make necessary factual determinations. 
 We thus affirm Appellants’ convictions.  However, we vacate Omar and Ahmad 
Desoky’s sentences, and remand for further factual findings.   
 
 
 
